Microthrombectomy reduces postsclerotherapy pigmentation: Multicenter randomized trial

Journal of Vascular Surgery

Volumn 38, Issue 5, 2003, Pages 896-903

  Scultetus, Anke H ^a   Villavicencio, J Leonel ^a   Kao, Tzu Cheg ^a   Gillespie, David L ^a   Ketron, Gary D ^b   Iafrati, Mark D ^c   Pikoulis, Emmanouil ^a   Eifert, Sandra ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRADECYL SULFATE SODIUM;

ADULT; AGED; ANAPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DYSPNEA; EDEMA; FEMALE; HEART DISEASE; HUMAN; HYPERPIGMENTATION; HYPOTENSION; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROTHROMBECTOMY; MULTICENTER STUDY; NAUSEA; NEOVASCULARIZATION (PATHOLOGY); PAIN; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; SCORING SYSTEM; SKIN NECROSIS; SKIN PIGMENTATION; SURGICAL TECHNIQUE; SYNCOPE; THROMBECTOMY; TREATMENT OUTCOME; VARICOSIS; VEIN DIAMETER; VEIN THROMBOSIS; VERTIGO; VISUAL DISORDER; VOMITING;

EID: 0242575939     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00920-0     Document Type: Conference Paper

References (35)

1. McPheeters HO. Injection treatment of varicose veins by the use of sclerosing solutions. Surg Gynecol Obstet 1927;45:541-7.
2. Dixon FC. The results of injection treatment of varicose veins. Proc Staff Meet Mayo Clin 1930;5:42.
3. Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy: etiology, prevention, and treatment. Dermatol Surg 1995;21:19-29.
4. Duffy DM. Small vessel sclerotherapy: an overview. Adv Dermatol 1988;3:221-40.
5. Ouvry PA. Telangiectasia and sclerotherapy. J Dermatol Surg Oncol 1989;15:177-81.
6. Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 1987;13:547-50.
7. Villavicencio JL, Spence RK, Pfeifer JR, Lohr JM, Cranley R, Goldman MP, et al. Sclerotherapy for varicose veins: guidelines and procedures. In: Raju S, Villavicencio JL, editors. Surgical management of Venous disease. Baltimore, Md: Williams & Wilkins; 1997. p 221-46.
8. Biegeleisen HI. Varicose veins, related diseases and sclerotherapy: a guide for practitioners. Toronto: Eden Press; 1984.
9. Chatard H. [Discussion of the question of J.-C. Allart. Pigmentations post-sclerotherapy.] Phlebologie 1976;29:211-6.
10. Goldman MP, Kaplan RP, Oki LN, Bennett RG, Strick RA. Extravascular effects of sclerosants in rabbit skin: a clinical and histologic examination of intradermal aethoxysklerol, sotradecol, and hypertonic saline. J Dermatol Surg Oncol 1986;12:1085-8.
11. Georgiev M. Postsclerotherapy hyperpigmentations: a one-year follow-up. J Dermatol Surg Oncol 1990;16:608-10.
12. Sadick NS, Weiss R. The utilization of a new yellow light laser (578 nm) for the treatment of class I red telangiectasia of the lower extremities. Dermatol Surg 2002;28:21-5.
13. Eremia S, Li CY. Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd: YAG laser: a prospective study of 47 patients. J Cosmet Laser Ther 2001;3:147-53.
14. Tafazzoli A, Rostan EF, Goldman MP. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation. Dermatol Surg 2000;26:653-6.
15. Sladen GJ, Reid JDS. Compression sclerotherapy for large varicose veins and perforator veins: a personal technique. In: Bergan JJ, Goldman MP, editors. Varicose veins and telangiectasias: diagnosis and treatment. St Louis, Mo: Quality Medical Publishing; 1993, p 208-25.
16. Cornu-Thenard A, Boivin P. Treatment of varicose veins by sclerotherapy: an overview. In: Bergan JJ, Goldman MP, editors. Varicose veins and telangiectasias: diagnosis and treatment. St Louis, Mo: Quality Medical Publishing; 1993. p 189-207.
17. Goldman MP. Complications and adverse sequelae of sclerotherapy. In: Goldman MP, editor. Sclerotherapy, 2nd edition. St Louis, Mo: Mosby-Year Book; 1995. p 280-349.
18. Duffy DM. Techniques of small vessel sclerotherapy. In: Goldman MP, Weiss RA, Bergan JJ, editors. Varicose veins and telangiectasias: diagnosis and treatment. St Louis, Mo: Quality Medical Publishing; 1999. p 518-47.
19. Davis LT, Dufffy DM. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol 1990;16:327-30.
20. Goldman MP. Complications and adverse sequelae of sclerotherapy. In: Goldman MP, Weiss RA, Bergan JJ, editors. Varicose veins and telangiecrasias: diagnosis and treatment. St Louis, Mo: Quality Medical Publishing; 1999. p 300-79.
21. Bihari I, Magyar E. Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg 2001;27:133-6.
22. Cacciatore E. Experience with aetoxisclerol in sclerotherapy. Minerva Cardioangiol 1979;27:255-62.
23. Goldman MP. Sclerotherapy of superficial venules and telangiectasias of the lower extremities. Dermatol Clin 1987;5:369-79.
24. Alderman DB. Surgery and sclerotherapy in the treatment of varicose veins. Conn Med 1975;39:467-71.
25. Bodian EL. Techniques of sclerotherapy for sunburst venous blemishes. J Dermatol Surg Oncol. 1985;11:696-704.
26. Weiss RA, Weiss MA. Resolution of pain associated with varicose and telangiectatic leg veins after compression therapy. J Dermatol Surg Oncol 1990;16:333-6.
27. Scott C, Seiger E. Postsclerotherapy pigmentation: is serum ferritin level an accurate indicator? Dermatol Surg 1997;23:281-2.
28. Weiss RA, Sadick NS, Goldman MP, Weiss MA. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25:105-8.
29. Omura NE, Dover JS, Arndt KA, Kauvar AN. Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. J Am Acad Dermatol 2003;48:76-81.
30. Lupton JR, Alster TS, Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg 2002;28:694-7.
31. Coles CM, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse Nd:YAG laser and sclerotherapy. Laser Surg Med 2002;30:154-9.
32. Goldman MP. Postsclerotherapy hyperpigmentation: treatment with a flashlamp-excited pulsed dye laser. J Dermatol Surg Oncol 1992;18:417-22.
33. Dover JS, Sadick NS, Goldman MP. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg 1999;25:328-35.
34. Lopez L, Dilley RB, Henriquez JA. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate. Dermatol Surg 2001;27:795-8.
35. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003;16:101-10.